Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Oncologic Emergencies: Gastroenterology

  • Chapter
  • First Online:
Oncologic Emergency Medicine

  • 1382 Accesses

Abstract

Technologic advances in gastroenterology (GI) have changed the nature of GI’s involvement in cancer care from staging to surveillance to management of tumor or treatment-related emergencies. GI-related oncologic emergencies represent a small proportion of all oncologic emergencies. This chapter discusses the most important including GI bleeding, luminal and biliary obstruction, acute pancreatitis, hepatic decompensation, and dislodgement of enteral devices. These disorders require early recognition so that management can be directed efficiently. A multidisciplinary approach to such patients and conditions including consultation with oncology, radiation oncology, surgery, primary care, and gastroenterology to assist in management, which may include a therapeutic GI procedure, is likely to lead to optimal patient outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Marmo R, Del Piano M, Rotondano G, et al. Mortality from nonulcer bleeding is similar to that of ulcer bleeding in high-risk patients with nonvariceal hemorrhage: a prospective database study in Italy. Gastrointest Endosc. 2012;75(2):263–72, 272.e1.

    Article  PubMed  Google Scholar 

  2. Savides TJ, Jensen DM, Cohen J, et al. Severe upper gastrointestinal tumor bleeding: endoscopic findings, treatment, and outcome. Endoscopy. 1996;28(2):244–8.

    Article  CAS  PubMed  Google Scholar 

  3. Boskoski I, Familiari P, Costamagna G. New and emerging endoscopic therapies for gastrointestinal bleeding. Curr Opin Gastroenterol. 2014;30(5):439–43.

    Article  PubMed  Google Scholar 

  4. Asge Technology Committee, Conway JD, Adler DG, et al. Endoscopic hemostatic devices. Gastrointest Endosc. 2009;69(6):987–96.

    Article  Google Scholar 

  5. Schwesinger WH, Chumley DL. Laser palliation for gastrointestinal malignancy. Am Surg. 1988;54(2):100–4.

    CAS  PubMed  Google Scholar 

  6. Suzuki H, Miho O, Watanabe Y, Kohyama M, Nagao F. Endoscopic laser therapy in the curative and palliative treatment of upper gastrointestinal cancer. World J Surg. 1989;13(2):158–64.

    Article  CAS  PubMed  Google Scholar 

  7. Loftus EV, Alexander GL, Ahlquist DA, Balm RK. Endoscopic treatment of major bleeding from advanced gastroduodenal malignant lesions. Mayo Clin Proc. 1994;69(8):736–40.

    Article  CAS  PubMed  Google Scholar 

  8. Eckhauser ML. Laser therapy of gastrointestinal tumors. World J Surg. 1992;16(6):1054–9.

    Article  CAS  PubMed  Google Scholar 

  9. Mathus-Vliegen EM, Tytgat GN. Analysis of failures and complications of neodymium: YAG laser photocoagulation in gastrointestinal tract tumors. A retrospective survey of 18 years’ experience. Endoscopy. 1990;22(1):17–23.

    Article  CAS  PubMed  Google Scholar 

  10. Kanai M, Hamada A, Endo Y, et al. Efficacy of argon plasma coagulation in nonvariceal upper gastrointestinal bleeding. Endoscopy. 2004;36(12):1085–8.

    Article  CAS  PubMed  Google Scholar 

  11. Wahab PJ, Mulder CJ, den Hartog G, Thies JE. Argon plasma coagulation in flexible gastrointestinal endoscopy: pilot experiences. Endoscopy. 1997;29(3):176–81.

    Article  CAS  PubMed  Google Scholar 

  12. Akhtar K, Byrne JP, Bancewicz J, Attwood SE. Argon beam plasma coagulation in the management of cancers of the esophagus and stomach. Surg Endosc. 2000;14(12):1127–30.

    Article  CAS  PubMed  Google Scholar 

  13. Shaheen NJ, Peery AF, Overholt BF, et al. Biopsy depth after radiofrequency ablation of dysplastic Barrett’s esophagus. Gastrointest Endosc. 2010;72(3):490–496.e1.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Shah MB, Schnoll-Sussman F. Novel use of cryotherapy to control bleeding in advanced esophageal cancer. Endoscopy. 2010;42 Suppl 2:9. E46-0029-1215370.

    Google Scholar 

  15. Babiuc RD, Purcarea M, Sadagurschi R, Negreanu L. Use of hemospray in the treatment of patients with acute UGIB – short review. J Med Life. 2013;6(2):117–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Bustamante-Balen M, Plume G. Role of hemostatic powders in the endoscopic management of gastrointestinal bleeding. World J Gastrointest Pathophysiol. 2014;5(3):284–92.

    PubMed  PubMed Central  Google Scholar 

  17. Chen YI, Barkun AN, Soulellis C, Mayrand S, Ghali P. Use of the endoscopically applied hemostatic powder TC-325 in cancer-related upper GI hemorrhage: preliminary experience (with video). Gastrointest Endosc. 2012;75(6):1278–81.

    Article  PubMed  Google Scholar 

  18. Leblanc S, Vienne A, Dhooge M, Coriat R, Chaussade S, Prat F. Early experience with a novel hemostatic powder used to treat upper GI bleeding related to malignancies or after therapeutic interventions (with videos). Gastrointest Endosc. 2013;78(1):169–75.

    Article  PubMed  Google Scholar 

  19. Ozaslan E, Purnak T, Yildiz A, Akar T, Avcioglu U, Haznedaroglu IC. The effect of ankaferd blood stopper on severe radiation colitis. Endoscopy. 2009;41 Suppl 2:E321–2.

    Article  PubMed  Google Scholar 

  20. Kurt M, Akdogan M, Onal IK, et al. Endoscopic topical application of ankaferd blood stopper for neoplastic gastrointestinal bleeding: a retrospective analysis. Dig Liver Dis. 2010;42(3):196–9.

    Article  PubMed  Google Scholar 

  21. Cheng AW, Chiu PW, Chan PC, Lam SH. Endoscopic hemostasis for bleeding gastric stromal tumors by application of hemoclip. J Laparoendosc Adv Surg Tech A. 2004;14(3):169–71.

    Article  PubMed  Google Scholar 

  22. Heller SJ, Tokar JL, Nguyen MT, Haluszka O, Weinberg DS. Management of bleeding GI tumors. Gastrointest Endosc. 2010;72(4):817–24.

    Article  PubMed  Google Scholar 

  23. Chaw CL, Niblock PG, Chaw CS, Adamson DJ. The role of palliative radiotherapy for haemostasis in unresectable gastric cancer: a single-institution experience. Ecancermed Sci. 2014;8:384.

    Google Scholar 

  24. Blackshaw GR, Stephens MR, Lewis WG, et al. Prognostic significance of acute presentation with emergency complications of gastric cancer. Gastric Cancer. 2004;7(2):91–6.

    Article  PubMed  Google Scholar 

  25. Vasas P, Wiggins T, Chaudry A, Bryant C, Hughes FS. Emergency presentation of the gastric cancer; prognosis and implications for service planning. World J Emerg Surg. 2012;7(1):31. -7922-7-31.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Saidi RF, ReMine SG, Dudrick PS, Hanna NN. Is there a role for palliative gastrectomy in patients with stage IV gastric cancer? World J Surg. 2006;30(1):21–7.

    Article  PubMed  Google Scholar 

  27. Greenall M, Barr H. Carcinoma of the stomach. In: Morris PJ, editor. Oxford textbook of surgery. Oxford: Oxford University Press; 2000. p. 1325.

    Google Scholar 

  28. Lupascu C, Andronic D, Ursulescu C, et al. Palliative gastrectomy in patients with stage IV gastric cancer – our recent experience. Chirurgia (Bucur). 2010;105(4):473–6.

    CAS  Google Scholar 

  29. Schultheiss TE, Lee WR, Hunt MA, Hanlon AL, Peter RS, Hanks GE. Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 1997;37(1):3–11.

    Article  CAS  PubMed  Google Scholar 

  30. Beard CJ, Propert KJ, Rieker PP, et al. Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes study. J Clin Oncol. 1997;15(1):223–9.

    CAS  PubMed  Google Scholar 

  31. Chon BH, Loeffler JS. The effect of nonmalignant systemic disease on tolerance to radiation therapy. Oncologist. 2002;7(2):136–43.

    Article  PubMed  Google Scholar 

  32. Kochhar R, Sriram PV, Sharma SC, Goel RC, Patel F. Natural history of late radiation proctosigmoiditis treated with topical sucralfate suspension. Dig Dis Sci. 1999;44(5):973–8.

    Article  CAS  PubMed  Google Scholar 

  33. Sasai T, Hiraishi H, Suzuki Y, Masuyama H, Ishida M, Terano A. Treatment of chronic post-radiation proctitis with oral administration of sucralfate. Am J Gastroenterol. 1998;93(9):1593–5.

    Article  CAS  PubMed  Google Scholar 

  34. Chun M, Kang S, Kil HJ, Oh YT, Sohn JH, Ryu HS. Rectal bleeding and its management after irradiation for uterine cervical cancer. Int J Radiat Oncol Biol Phys. 2004;58(1):98–105.

    Article  PubMed  Google Scholar 

  35. Taylor JG, DiSario JA, Buchi KN. Argon laser therapy for hemorrhagic radiation proctitis: long-term results. Gastrointest Endosc. 1993;39(5):641–4.

    Article  CAS  PubMed  Google Scholar 

  36. Sarin A, Safar B. Management of radiation proctitis. Gastroenterol Clin North Am. 2013;42(4):913–25.

    Article  PubMed  Google Scholar 

  37. Karamanolis G, Triantafyllou K, Tsiamoulos Z, et al. Argon plasma coagulation has a long-lasting therapeutic effect in patients with chronic radiation proctitis. Endoscopy. 2009;41(6):529–31.

    Article  CAS  PubMed  Google Scholar 

  38. Karamanolis G, Psatha P, Triantafyllou K. Endoscopic treatments for chronic radiation proctitis. World J Gastrointest Endosc. 2013;5(7):308–12.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Eddi R, Depasquale JR. Radiofrequency ablation for the treatment of radiation proctitis: a case report and review of literature. Therap Adv Gastroenterol. 2013;6(1):69–76.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Zhou C, Adler DC, Becker L, et al. Effective treatment of chronic radiation proctitis using radiofrequency ablation. Therap Adv Gastroenterol. 2009;2(3):149–56.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Moawad FJ, Maydonovitch CL, Horwhat JD. Efficacy of cryospray ablation for the treatment of chronic radiation proctitis in a pilot study. Dig Endosc. 2013;25(2):174–9.

    Article  PubMed  Google Scholar 

  42. Moawad FJ, Horwhat JD. Cryotherapy for treatment of radiation proctitis. Gastrointest Endosc. 2014;79(2):209–10.

    Article  PubMed  Google Scholar 

  43. Bosscher MR, van Leeuwen BL, Hoekstra HJ. Surgical emergencies in oncology. Cancer Treat Rev. 2014;40(8):1028–36.

    Article  CAS  PubMed  Google Scholar 

  44. Sharma P, Kozarek R. Practice Parameters Committee of American College of Gastroenterology. Role of esophageal stents in benign and malignant diseases. Am J Gastroenterol. 2010;105(2):258–73. doi:10.1038/ajg.2009.684. quiz 274.

    Article  PubMed  Google Scholar 

  45. Siddiqui AA, Sarkar A, Beltz S, et al. Placement of fully covered self-expandable metal stents in patients with locally advanced esophageal cancer before neoadjuvant therapy. Gastrointest Endosc. 2012;76(1):44–51.

    Article  PubMed  Google Scholar 

  46. Ding NS, Alexander S, Swan MP, et al. Gastroduodenal outlet obstruction and palliative self-expandable metal stenting: a dual-centre experience. J Oncol. 2013;2013:167851.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Boskoski I, Tringali A, Familiari P, Mutignani M, Costamagna G. Self-expandable metallic stents for malignant gastric outlet obstruction. Adv Ther. 2010;27(10):691–703.

    Article  CAS  PubMed  Google Scholar 

  48. Larssen L, Medhus AW, Korner H, et al. Long-term outcome of palliative treatment with self-expanding metal stents for malignant obstructions of the GI tract. Scand J Gastroenterol. 2012;47(12):1505–14.

    Article  PubMed  Google Scholar 

  49. Larssen L, Hauge T, Medhus AW. Stent treatment of malignant gastric outlet obstruction: the effect on rate of gastric emptying, symptoms, and survival. Surg Endosc. 2012;26(10):2955–60.

    Article  PubMed  Google Scholar 

  50. Kaw M, Singh S, Gagneja H. Clinical outcome of simultaneous self-expandable metal stents for palliation of malignant biliary and duodenal obstruction. Surg Endosc. 2003;17(3):457–61.

    Article  CAS  PubMed  Google Scholar 

  51. Moon JH, Choi HJ, Ko BM, et al. Combined endoscopic stent-in-stent placement for malignant biliary and duodenal obstruction by using a new duodenal metal stent (with videos). Gastrointest Endosc. 2009;70(4):772–7.

    Article  PubMed  Google Scholar 

  52. Garcia-Cano J, Gonzalez-Huix F, Juzgado D, et al. Use of self-expanding metal stents to treat malignant colorectal obstruction in general endoscopic practice (with videos). Gastrointest Endosc. 2006;64(6):914–20.

    Article  PubMed  Google Scholar 

  53. van Hooft JE, Fockens P, Marinelli AW, et al. Early closure of a multicenter randomized clinical trial of endoscopic stenting versus surgery for stage IV left-sided colorectal cancer. Endoscopy. 2008;40(3):184–91.

    Article  PubMed  Google Scholar 

  54. Frago R, Kreisler E, Biondo S, et al. Complications of distal intestinal occlusion treatment with endoluminal implants. Cir Esp. 2011;89(7):448–55.

    Article  PubMed  Google Scholar 

  55. Cirocchi R, Farinella E, Trastulli S, et al. Safety and efficacy of endoscopic colonic stenting as a bridge to surgery in the management of intestinal obstruction due to left colon and rectal cancer: a systematic review and meta-analysis. Surg Oncol. 2013;22(1):14–21.

    Article  PubMed  Google Scholar 

  56. Xinopoulos D, Dimitroulopoulos D, Theodosopoulos T, et al. Stenting or stoma creation for patients with inoperable malignant colonic obstructions? Results of a study and cost-effectiveness analysis. Surg Endosc. 2004;18(3):421–6.

    Article  CAS  PubMed  Google Scholar 

  57. Fernandez-Esparrach G, Bordas JM, Giraldez MD, et al. Severe complications limit long-term clinical success of self-expanding metal stents in patients with obstructive colorectal cancer. Am J Gastroenterol. 2010;105(5):1087–93.

    Article  PubMed  Google Scholar 

  58. Frago R, Ramirez E, Millan M, Kreisler E, del Valle E, Biondo S. Current management of acute malignant large bowel obstruction: a systematic review. Am J Surg. 2014;207(1):127–38.

    Article  PubMed  Google Scholar 

  59. Lin A, Feller ER. Pancreatic carcinoma as a cause of unexplained pancreatitis: report of ten cases. Ann Intern Med. 1990;113(2):166–7.

    Article  CAS  PubMed  Google Scholar 

  60. Munigala S, Kanwal F, Xian H, Scherrer JF, Agarwal B. Increased risk of pancreatic adenocarcinoma after acute pancreatitis. Clin Gastroenterol Hepatol. 2014;12(7):1143–50.e1.

    Article  PubMed  Google Scholar 

  61. Tummala P, Tariq SH, Chibnall JT, Agarwal B. Clinical predictors of pancreatic carcinoma causing acute pancreatitis. Pancreas. 2013;42(1):108–13.

    Article  PubMed  Google Scholar 

  62. Tejedor Bravo M, Justo LM, Lasala JP, Moreira Vicente VF, Ruiz AC, Scapa Mde L. Acute pancreatitis secondary to neuroendocrine pancreatic tumors: report of 3 cases and literature review. Pancreas. 2012;41(3):485–9.

    Article  PubMed  Google Scholar 

  63. Vasiliadisl K, Papavasiliou C, Pervana S, Nikopoulos K, Makridis C. Acute pancreatitis as the initial manifestation of an adenocarcinoma of the major duodenal papilla in a patient with familial adenomatous polyposis syndrome: a case report and literature review. Acta Chir Belg. 2013;113(6):463–7.

    CAS  PubMed  Google Scholar 

  64. Stewart KC, Dickout WJ, Urschel JD. Metastasis-induced acute pancreatitis as the initial manifestation of bronchogenic carcinoma. Chest. 1993;104(1):98–100.

    Article  CAS  PubMed  Google Scholar 

  65. Sobesky R, Duclos-Vallee JC, Prat F, et al. Acute pancreatitis revealing diffuse infiltration of the pancreas by melanoma. Pancreas. 1997;15(2):213–5.

    Article  CAS  PubMed  Google Scholar 

  66. McIntosh J, Lauer J, Gunatilake R, Knudtson E. Multiple myeloma presenting as hypercalcemic pancreatitis during pregnancy. Obstet Gynecol. 2014;124(2 Pt 2 Suppl 1):461–3.

    Article  PubMed  Google Scholar 

  67. Rebours V, Boutron-Ruault MC, Schnee M, et al. The natural history of hereditary pancreatitis: a national series. Gut. 2009;58(1):97–103.

    Article  CAS  PubMed  Google Scholar 

  68. Lu L, Lou Y, Tan H. Chemotherapy-induced fulminant acute pancreatitis in pancreatic carcinoma: a case report. Oncol Lett. 2014;8(3):1143–6.

    PubMed  PubMed Central  Google Scholar 

  69. Davila M, Bresalier RS. Gastrointestinal complications of oncologic therapy. Nat Clin Pract Gastroenterol Hepatol. 2008;5(12):682–96.

    Article  PubMed  Google Scholar 

  70. Tenner S, Baillie J, DeWitt J, Vege SS, American College of Gastroenterology. American college of gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013;108(9):1400–15, 16.

    Article  CAS  PubMed  Google Scholar 

  71. Wu BU, Banks PA. Clinical management of patients with acute pancreatitis. Gastroenterology. 2013;144(6):1272–81.

    Article  PubMed  Google Scholar 

  72. Fisher JM, Gardner TB. The “golden hours” of management in acute pancreatitis. Am J Gastroenterol. 2012;107(8):1146–50.

    Article  PubMed  Google Scholar 

  73. Al-Omran M, Albalawi ZH, Tashkandi MF, Al-Ansary LA. Enteral versus parenteral nutrition for acute pancreatitis. Cochrane Database Syst Rev. 2010;1:002837.

    Google Scholar 

  74. Boulay BR, Gardner TB, Gordon SR. Occlusion rate and complications of plastic biliary stent placement in patients undergoing neoadjuvant chemoradiotherapy for pancreatic cancer with malignant biliary obstruction. J Clin Gastroenterol. 2010;44(6):452–5.

    CAS  PubMed  Google Scholar 

  75. Siddiqui AA, Mehendiratta V, Loren D, et al. Self-expanding metal stents (SEMS) for preoperative biliary decompression in patients with resectable and borderline-resectable pancreatic cancer: outcomes in 241 patients. Dig Dis Sci. 2013;58(6):1744–50.

    Article  CAS  PubMed  Google Scholar 

  76. Alexopoulou A, Koskinas J, Deutsch M, Delladetsima J, Kountouras D, Dourakis SP. Acute liver failure as the initial manifestation of hepatic infiltration by a solid tumor: report of 5 cases and review of the literature. Tumori. 2006;92(4):354–7.

    PubMed  Google Scholar 

  77. Rowbotham D, Wendon J, Williams R. Acute liver failure secondary to hepatic infiltration: a single centre experience of 18 cases. Gut. 1998;42(4):576–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Runyon BA, Hoefs JC, Morgan TR. Ascitic fluid analysis in malignancy-related ascites. Hepatology. 1988;8(5):1104–9.

    Article  CAS  PubMed  Google Scholar 

  79. Hoefs JC. Serum protein concentration and portal pressure determine the ascitic fluid protein concentration in patients with chronic liver disease. J Lab Clin Med. 1983;102(2):260–73.

    CAS  PubMed  Google Scholar 

  80. Runyon BA, Montano AA, Akriviadis EA, Antillon MR, Irving MA, McHutchison JG. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann Intern Med. 1992;117(3):215–20.

    Article  CAS  PubMed  Google Scholar 

  81. Popovich MJ, Lockrem JD, Zivot JB. Nasal bridle revisited: an improvement in the technique to prevent unintentional removal of small-bore nasoenteric feeding tubes. Crit Care Med. 1996;24(3):429–31.

    Article  CAS  PubMed  Google Scholar 

  82. Seder CW, Stockdale W, Hale L, Janczyk RJ. Nasal bridling decreases feeding tube dislodgment and may increase caloric intake in the surgical intensive care unit: a randomized, controlled trial. Crit Care Med. 2010;38(3):797–801.

    Article  PubMed  Google Scholar 

  83. Seder CW, Janczyk R. The routine bridling of nasojejunal tubes is a safe and effective method of reducing dislodgement in the intensive care unit. Nutr Clin Pract. 2008;23(6):651–4.

    Article  PubMed  Google Scholar 

  84. Taheri MR, Singh H, Duerksen DR. Peritonitis after gastrostomy tube replacement: a case series and review of literature. J Parenter Enteral Nutr. 2011;35(1):56–60.

    Article  Google Scholar 

  85. ASGE Training Committee 2013-2014, Enestvedt BK, Jorgensen J, et al. Endoscopic approaches to enteral feeding and nutrition core curriculum. Gastrointest Endosc. 2014;80(1):34–41.

    Article  Google Scholar 

  86. Technology Committee ASGE, Kwon RS, Banerjee S, et al. Enteral nutrition access devices. Gastrointest Endosc. 2010;72(2):236–48.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology & Hepatology, Department of Medicine, Oregon Health & Science University, Portland, OR, USA

    Brintha K. Enestvedt MD, MBA & Gene Bakis MD

  2. Department of Gastroenterology, Temple University, Philadelphia, PA, USA

    Jennifer L. Maranki MD

Authors
  1. Brintha K. Enestvedt MD, MBA
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jennifer L. Maranki MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gene Bakis MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Brintha K. Enestvedt MD, MBA .

Editor information

Editors and Affiliations

  1. Houston, Texas, USA

    Knox H. Todd

  2. Portland, Oregon, USA

    Charles R. Thomas, Jr.

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Enestvedt, B.K., Maranki, J.L., Bakis, G. (2016). Oncologic Emergencies: Gastroenterology. In: Todd, K., Thomas, Jr., C. (eds) Oncologic Emergency Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-26387-8_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-26387-8_24

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-26385-4

  • Online ISBN: 978-3-319-26387-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation